Global professional services firm Alvarez & Marsal (A&M) appointed managing director Harry Kim within its life sciences (LS) group. Kim’s appointment follows on A&M’s life science offering investments demonstrated by recent managing director hires James Guyton, Frank Orlowski and Rena Rosenberg.
With more than a quarter century of life sciences and healthcare experience, Kim specializes in meshing cutting-edge technology into the highly regulated life science and healthcare ecosystem to access to new services, bend the cost curve of care delivery and transform the patient experience.
Kim’s notable achievements include building a $1 billion new business (digital hospitals), delivering health services to over 65M monthly active users (global health app), developing industry-leading cardiac rehab-at-home service (wearable + app) and scaling telehealth adoption to millions of users. He has engaged with governments and enterprises on critical digital health implementation and delivery issues in over 40 countries.
“Harry’s joining our team is a game-changer. His unparalleled expertise in digital health and proven track record of driving innovation aligns perfectly with A&M’s commitment to delivering transformative solutions. His blend of consulting prowess and hands-on operating experience epitomizes A&M’s distinctive approach to client service,” Mark Freitas, managing director and life sciences practice leader, said. “Our team has walked in our clients’ shoes, giving us a deep understanding of what it takes to drive real change in organizations. This allows us to provide actionable recommendations and deliver tangible results that truly move the needle for our clients. Harry’s addition to our rapidly growing team is yet another signal of A&M’s momentum as the market increasingly seeks alternatives to traditional players.”
Prior to joining A&M, Kim served as global business leader for Samsung Health delivering services to over 360 million users on mobile and wearable platforms. He also served as Hewlett Packard’s global health and life sciences industry lead, growing that company’s business from $3 billion to over $11 billion in revenue during his tenure. Kim’s other roles include serving as chairman and CEO for a telehealth start-up pioneering a new digital therapeutic and as senior vice president and general manager for Amwell, a global telehealth leader.
Kim began his career as a consultant with EY and Deloitte. While serving at those firms, he led market transaction engagements including HP’s $18 billion IPO spin-off of Agilent Technologies and Agilent’s $1.7 billion health group sale to Philips.
“Our life sciences talent growth strategy is based on broadening the reach of A&M’s integrated platform to best meet client needs in a complex marketplace,” Tom Elsenbrook, a managing director and leader of A&M’s corporate performance improvement group, said. “Harry’s industry and big four experience provides clients with the roll-up-your-sleeves strategy implementation expertise necessary to navigate and thrive in a rapidly changing environment.”
“Our life sciences business unit is market-focused and supported by collaboration across the firm’s global platform of industry experts,” Martin McGahan, managing director and head of Alvarez & Marsal’s healthcare industry group, said. “A&M’s ability to seamlessly integrate a range of practitioner experience, such as Harry’s, fuels our collective power to help clients overcome industry pressures and aggressively pursue growth and sustained profitability.”
